Karachi: BF Biosciences Limited has scheduled a board meeting through video link on July 10, 2025, to deliberate on the annual budget for the fiscal year 2025-26. This decision aligns with the company’s strategic planning requirements and regulatory obligations.

The company announced a closed period from July 8 to July 10, 2025. This action is mandated under regulation 5.6.4 of the Pakistan Stock Exchange (PSX), ensuring that no trading in the company’s shares will take place during this time frame.

According to information available from the Pakistan Stock Exchange (PSX), the closed period is a measure designed to prevent insider trading ahead of significant corporate announcements. The designation of this period reflects the company’s adherence to market regulations.

BF Biosciences Limited, listed under the designated market category of pharmaceuticals, has not indicated any further agenda for the upcoming meeting apart from the budget discussion. This step is seen as part of the company’s routine governance practices.